<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8728196</article-id>
    <article-id pub-id-type="pmid">34850125</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkab1092</article-id>
    <article-id pub-id-type="publisher-id">gkab1092</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>LncACTdb 3.0: an updated database of experimentally supported ceRNA interactions and personalized networks contributing to precision medicine</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5716-9937</contrib-id>
        <name>
          <surname>Wang</surname>
          <given-names>Peng</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Guo</surname>
          <given-names>Qiuyan</given-names>
        </name>
        <aff><institution>Department of Gynecology, the First Affiliated Hospital of Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Qi</surname>
          <given-names>Yue</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hao</surname>
          <given-names>Yangyang</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gao</surname>
          <given-names>Yue</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9103-8642</contrib-id>
        <name>
          <surname>Zhi</surname>
          <given-names>Hui</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Yuanfu</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sun</surname>
          <given-names>Yue</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Yakun</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xin</surname>
          <given-names>Mengyu</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Yunpeng</given-names>
        </name>
        <!--zhangyp@hrbmu.edu.cn-->
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
        <xref rid="COR3" ref-type="corresp"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4079-8945</contrib-id>
        <name>
          <surname>Ning</surname>
          <given-names>Shangwei</given-names>
        </name>
        <!--ningsw@ems.hrbmu.edu.cn-->
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
        <xref rid="COR2" ref-type="corresp"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9794-2648</contrib-id>
        <name>
          <surname>Li</surname>
          <given-names>Xia</given-names>
        </name>
        <!--lixia@hrbmu.edu.cn-->
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150081, <country country="CN">China</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +86 451 86615922; Fax: +86 451 86615922; Email: <email>lixia@hrbmu.edu.cn</email></corresp>
      <corresp id="COR2">Correspondence may also be addressed to Shangwei Ning. Email: <email>ningsw@ems.hrbmu.edu.cn</email></corresp>
      <corresp id="COR3">Correspondence may also be addressed to YunPeng Zhang. Email: <email>zhangyp@hrbmu.edu.cn</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first four authors should be regarded as joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>07</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-11-26">
      <day>26</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>26</day>
      <month>11</month>
      <year>2021</year>
    </pub-date>
    <volume>50</volume>
    <issue>D1</issue>
    <fpage>D183</fpage>
    <lpage>D189</lpage>
    <history>
      <date date-type="accepted">
        <day>18</day>
        <month>11</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>10</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>9</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkab1092.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>LncACTdb 3.0 is a comprehensive database of experimentally supported interactions among competing endogenous RNA (ceRNA) and the corresponding personalized networks contributing to precision medicine. LncACTdb 3.0 is freely available at <ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/LncACTdb" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/LncACTdb</ext-link> or <ext-link xlink:href="http://www.bio-bigdata.net/LncACTdb" ext-link-type="uri">http://www.bio-bigdata.net/LncACTdb</ext-link>. We have updated the LncACTdb 3.0 database with several new features, including (i) 5669 experimentally validated ceRNA interactions across 25 species and 537 diseases/phenotypes through manual curation of published literature, (ii) personalized ceRNA interactions and networks for 16 228 patients from 62 datasets in TCGA and GEO, (iii) sub-cellular and extracellular vesicle locations of ceRNA manually curated from literature and data sources, (iv) more than 10 000 experimentally supported long noncoding RNA (lncRNA) biomarkers associated with tumor diagnosis and therapy, and (v) lncRNA/mRNA/miRNA expression profiles with clinical and pathological information of thousands of cancer patients. A panel of improved tools has been developed to explore the effects of ceRNA on individuals with specific pathological backgrounds. For example, a network tool provides a comprehensive view of lncRNA-related, patient-specific, and custom-designed ceRNA networks. LncACTdb 3.0 will provide novel insights for further studies of complex diseases at the individual level and will facilitate the development of precision medicine to treat such diseases.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Key Research and Development Program of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100012166</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2018YFC2000100</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>32070673</award-id>
        <award-id>32070622</award-id>
        <award-id>32070672</award-id>
        <award-id>61873075</award-id>
        <award-id>62172131</award-id>
        <award-id>81902646</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Heilongjiang Touyan Innovation Team Program</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Heilongjiang Provincial Natural Science Foundation</institution>
          </institution-wrap>
        </funding-source>
        <award-id>YQ2021C026</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Postdoctoral Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2020M670922</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Postdoctoral Foundation of Heilongjiang Province</institution>
          </institution-wrap>
        </funding-source>
        <award-id>LBH-Z19077</award-id>
        <award-id>LBH-Q20047</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="7"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>MicroRNAs (miRNAs) are a type of noncoding RNA capable of regulating gene expression by suppressing protein production via the inhibition of translation or by destabilizing mRNAs by directing RNA-induced silencing complexes (RISCs) to miRNA response elements (MREs) (<xref rid="B1" ref-type="bibr">1–3</xref>). MREs are localized not only on mRNAs but also on noncoding transcripts, such as pseudogenes and long noncoding RNAs (lncRNAs) (<xref rid="B4" ref-type="bibr">4</xref>). Essentially, each miRNA has several RNA targets, while numerous RNA molecules have various MREs that can be repressed by different miRNAs. This multiplicity of targets leads to the hypothesis that different RNAs compete for the restriction pool of miRNAs (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>), thereby acting as ceRNAs. The ceRNA hypothesis suggests that any RNA transcript harboring an MRE can sequester miRNAs from other targets sharing the same MRE, thus regulating their expression. Based on the ceRNA hypothesis, it has been proposed that a major function of noncoding RNAs (e.g. lncRNAs) may acting as decoys for endogenous miRNAs.</p>
    <p>Accumulating evidence suggests that the function of many noncoding RNAs in tumorigenesis may be partly mediated by ceRNA cross-talk (<xref rid="B7" ref-type="bibr">7</xref>). For example, lncRNA HULC was upregulated in hepatocellular carcinoma, and miR-372 was experimentally shown to bind to both HULC and PRKACB in hepatocellular carcinoma cells. HULC and PRKACB may regulate each other's expression by competing for the binding of miR-372 in hepatocellular carcinoma (<xref rid="B8" ref-type="bibr">8</xref>). A recent study revealed that the upregulation of HOTAIR is associated with an unfavorable gastric cancer prognosis and that the regulation of HER2 levels through ceRNA interactions may be one of the mechanisms underlying the oncogenic role of HOTAIR in gastric cancer (<xref rid="B9" ref-type="bibr">9</xref>). Based on ceRNA regulatory patterns in cancer, researchers can develop new therapeutic strategies and discover cancer biomarkers.</p>
    <p>As more ceRNAs have been proven to play roles in diseases and the advent of high-throughput and single-cell sequencing technologies, the number of experimentally confirmed ceRNA relationships has increased dramatically, necessitating the collection and organization of this information to facilitate extraction and utilization. Many databases have been established to collect lncRNA–target relationships, such as LncTarD (<xref rid="B10" ref-type="bibr">10</xref>), lnCeDB (<xref rid="B11" ref-type="bibr">11</xref>), starBase v2.0 (<xref rid="B12" ref-type="bibr">12</xref>), DIANA-LncBase v3 (<xref rid="B13" ref-type="bibr">13</xref>), miRSponge (<xref rid="B14" ref-type="bibr">14</xref>) and PceRBase (<xref rid="B15" ref-type="bibr">15</xref>). These databases provide valuable resources for studying lncRNA functions. However, they have a very limited collection of experimentally supported ceRNAs. We have developed a database for collecting, storing, and analyzing experimentally supported ceRNA interactions and comprehensive annotations: LncACTdb (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>). Since its first release in 2015, more ceRNA interactions have been published, particularly experimentally validated ones in various disease states, and a public resource of high-quality curated experimentally validated ceRNA interactions and personalized ceRNA networks remain unavailable. Therefore, there is a great need to update LncACTdb with more resources and improved tools.</p>
    <p>To meet these requirements, we have updated LncACTdb to version 3.0 (LncACTdb 3.0) with more data and newer features focusing on personalized ceRNA networks (Table <xref rid="tbl1" ref-type="table">1</xref>). The current version of LncACTdb documents &gt;5000 experimentally validated ceRNA interactions across 25 species and 537 diseases/phenotypes via manual curation of &gt;6000 published literature. Newly identified personalized lncRNA-associated ceRNA interactions and networks for 16 228 patients from 62 datasets in The Cancer Genome Atlas (TCGA) (<ext-link xlink:href="https://portal.gdc.cancer.gov" ext-link-type="uri">https://portal.gdc.cancer.gov</ext-link>) and Gene Expression Omnibus (GEO) (<xref rid="B18" ref-type="bibr">18</xref>) have been integrated into LncACTdb 3.0 (Figure <xref rid="F1" ref-type="fig">1</xref>). To provide a more comprehensive annotation of lncRNAs, more than 10 000 experimentally supported lncRNA biomarkers associated with tumor metastasis (e.g. recurrence, prognosis, circulation and drug resistance) have been collected. LncACTdb 3.0 also provides detailed information of sub-cellular and extracellular locations by manual curation from literature and related data sources (<xref rid="B19" ref-type="bibr">19–23</xref>). By incorporating personalized ceRNA networks, the curation of lncRNA/mRNA/miRNA expression profiles and clinical information such as metastasis, recurrence, drug resistance, and prognosis from thousands of patients were integrated into LncACTdb 3.0 to perform individual pathology analysis. Furthermore, as an important supplement to the database, we set up several flexible tools to retrieve and analyze the data in LncACTdb 3.0. For example, the LncACT-Tree is a tool used to visualize ceRNA distributions and survival status across different patients, and the LncACT-Network is used to contribute a ceRNA network based on the dataset, individual, and molecular levels. Moreover, the identification of patient-specific gene regulation networks will help understanding the disease pathology at the individual level and further contribute to precision medicine. Collectively, this updated database could facilitate the identification of disease-associated ceRNAs and benefit the investigation of their roles in physiological and pathological processes.</p>
    <table-wrap position="float" id="tbl1">
      <label>Table 1.</label>
      <caption>
        <p>Data content and improved functions of LncACTdb 3.0</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th colspan="2" align="left" rowspan="1">Datasets and features</th>
            <th rowspan="1" colspan="1">LncACTdb 2.0</th>
            <th rowspan="1" colspan="1">LncACTdb 3.0</th>
            <th rowspan="1" colspan="1">Fold increase</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Experimental dataset</td>
            <td rowspan="1" colspan="1">CeRNA interactions</td>
            <td rowspan="1" colspan="1">2663</td>
            <td rowspan="1" colspan="1">5669</td>
            <td rowspan="1" colspan="1">2.13</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">LncRNAs</td>
            <td rowspan="1" colspan="1">312</td>
            <td rowspan="1" colspan="1">913</td>
            <td rowspan="1" colspan="1">2.92</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">MiRNAs</td>
            <td rowspan="1" colspan="1">479</td>
            <td rowspan="1" colspan="1">1048</td>
            <td rowspan="1" colspan="1">2.19</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">CircRNAs</td>
            <td rowspan="1" colspan="1">59</td>
            <td rowspan="1" colspan="1">337</td>
            <td rowspan="1" colspan="1">5.71</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">MRNAs</td>
            <td rowspan="1" colspan="1">131</td>
            <td rowspan="1" colspan="1">1723</td>
            <td rowspan="1" colspan="1">13.15</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Pseudogenes</td>
            <td rowspan="1" colspan="1">16</td>
            <td rowspan="1" colspan="1">19</td>
            <td rowspan="1" colspan="1">1.19</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Species</td>
            <td rowspan="1" colspan="1">23</td>
            <td rowspan="1" colspan="1">25</td>
            <td rowspan="1" colspan="1">1.09</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Diseases/Phenotypes</td>
            <td rowspan="1" colspan="1">213</td>
            <td rowspan="1" colspan="1">537</td>
            <td rowspan="1" colspan="1">2.52</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Predicted dataset</td>
            <td rowspan="1" colspan="1">CeRNA interactions</td>
            <td rowspan="1" colspan="1">47 673</td>
            <td rowspan="1" colspan="1">93 762</td>
            <td rowspan="1" colspan="1">1.97</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">LncRNAs</td>
            <td rowspan="1" colspan="1">1191</td>
            <td rowspan="1" colspan="1">2679</td>
            <td rowspan="1" colspan="1">2.25</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">MiRNAs</td>
            <td rowspan="1" colspan="1">502</td>
            <td rowspan="1" colspan="1">806</td>
            <td rowspan="1" colspan="1">1.61</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">MRNAs</td>
            <td rowspan="1" colspan="1">2792</td>
            <td rowspan="1" colspan="1">9198</td>
            <td rowspan="1" colspan="1">3.29</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Datasets</td>
            <td rowspan="1" colspan="1">33</td>
            <td rowspan="1" colspan="1">62</td>
            <td rowspan="1" colspan="1">1.98</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Patients</td>
            <td rowspan="1" colspan="1">10 141</td>
            <td rowspan="1" colspan="1">16 228</td>
            <td rowspan="1" colspan="1">1.60</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Functional annotations</td>
            <td rowspan="1" colspan="1">Diagnosis and therapy Biomarkers</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">10 084</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Sub-cellular locations</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">21 751</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Extra-cellular locations</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">89 925</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Cancer cell states</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">14 states, 1574 genes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">LncRNA-ceRNA networks</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Patient-specific ceRNA networks</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Custome-designed</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">Yes</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">Clinical and pathological information</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">Stage, grade, metastasis, recurrence, drug-resistance, survival status, etc.</td>
            <td rowspan="1" colspan="1">New</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>Data expansion and features of LncACTdb 3.0. The upper panel is the database content which includes experimentally validated ceRNAs and predicted patient-specific networks, and web tools construction. The lower panel is the user interface of LncACTdb 3.0, which provides flexible ways to explore effects of ceRNA on patients with complex diseases and specific backgrounds.</p>
      </caption>
      <graphic xlink:href="gkab1092fig1" position="float"/>
    </fig>
  </sec>
  <sec id="SEC2">
    <title>IMPROVED EXPANSION AND NEW FEATURES</title>
    <sec id="SEC2-1">
      <title>Expansion of experimentally supported ceRNAs</title>
      <p>LncACTdb 3.0 was updated to host an increased number and types of ceRNA associations (Figure <xref rid="F1" ref-type="fig">1</xref>). In this update, we reviewed published literature from the PubMed database using keywords related to ceRNA interactions and found &gt;15 000 relevant articles (before September 2021, Supplementary Methods). From 2018 to 2021, there was a great increase in ceRNA-related studies (∼10 000 articles), indicating an urgent need to update the LncACTdb database (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>). Based on these articles, we manually curated experimentally supported ceRNA interactions according to our previously defined criteria (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref>). Only ceRNA interactions validated by high-confidence experiments such as luciferase reporter assay, PCR, western blot, or other reliable experiments were considered as candidates. A candidate ceRNA interaction was confirmed by at least two researchers and catalogued into the curation. Detailed information on the data curation pipeline and principles are provided in the Supplementary Methods. The current version of LncACTdb documents 5669 experimentally supported ceRNA interactions, including 913 lncRNAs, 1723 mRNAs, 337 circRNAs and 19 pseudogenes. The scope of LncACTdb 3.0 has been expanded to 25 species and 537 diseases/phenotypes.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Manual curation of experimentally supported biomarkers</title>
      <p>Emerging evidence suggests that lncRNAs play an important role in ceRNA regulation (<xref rid="B26" ref-type="bibr">26</xref>). The upstream lncRNA can dynamically buffer target expression and further affect different physiological and pathological processes (<xref rid="B27" ref-type="bibr">27</xref>). Some well-known lncRNAs, such as MALAT1, have been identified as biomarkers for metastasis, recurrence, and potential drug targets (<xref rid="B28" ref-type="bibr">28</xref>). In LncACTdb 3.0, we performed manual curation of experimentally supported lncRNA biomarkers to provide new insights into tumor diagnosis and therapy. According to our previous studies (<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B29" ref-type="bibr">29</xref>), the biological processes associated with these lncRNA biomarkers were classified as autophagy, apoptosis, cell growth, circulation, drug resistance, epithelial-mesenchymal transition (EMT), immunity, metastasis, recurrence, and survival (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2</xref>). Only lncRNAs involved in these processes were collected by high-confidence experiments (Supplementary Methods). LncACTdb 3.0 currently documents a total of 10 084 experimentally supported lncRNA biomarkers.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Manual curation of functional annotations</title>
      <p>In the previous version (LncACTdb 2.0), a ‘guilt-by-association’ strategy was used for functional annotation of ceRNAs (Supplementary Methods, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S3</xref>) (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>). To provide a more comprehensive annotation background, LncACTdb 3.0 also collected thousands of pathways including KEGG (<xref rid="B21" ref-type="bibr">21</xref>), Reactome (<xref rid="B22" ref-type="bibr">22</xref>) and PID (<xref rid="B23" ref-type="bibr">23</xref>). For Gene Ontology (GO) annotation (<xref rid="B25" ref-type="bibr">25</xref>), thousands of gene sets representing functional terms were integrated. Furthermore, we manually curated gene sets of 10 classic cancer hallmark processes (<xref rid="B30" ref-type="bibr">30</xref>) and 14 functional states of tumor cells (<xref rid="B31" ref-type="bibr">31</xref>) into LncACTdb 3.0, to explore the regulatory mechanisms of ceRNAs at the individual level (Supplementary Methods, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S4</xref>). Moreover, 111 676 entries illustrating sub-cellular and extracellular vesicle locations of lncRNAs, miRNAs and mRNAs were collected by manual curation from related data sources and literature (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S5</xref>).</p>
    </sec>
    <sec id="SEC2-4">
      <title>Identification of patient-specific ceRNAs and networks</title>
      <p>Under the complex microenvironment of tumors, patients with the same disease may exhibit different behaviors driven by the fine-tuning of ceRNA regulation (<xref rid="B29" ref-type="bibr">29</xref>). Thus, the identification of patient-specific ceRNA and networks will deepen the understanding of disease pathology and contribute to the development of precision medicine. ceRNA regulations of a total of 108 668 candidates were downloaded from starBase (v2.0) (<xref rid="B12" ref-type="bibr">12</xref>) and LncACTdb (v2.0) (<xref rid="B17" ref-type="bibr">17</xref>). In this study, we used a published method (<xref rid="B32" ref-type="bibr">32</xref>), which was developed based on probability theory, to identify patient-specific ceRNAs and networks across different datasets (Supplementary Methods, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S6</xref>). This strategy was utilized in our previous study to construct ceRNA networks at single-cell resolution (<xref rid="B29" ref-type="bibr">29</xref>). Briefly, the association of a ceRNA interaction (lncRNA–mRNA) within a specific sample was estimated by testing the statistical independence of lncRNA and mRNA expression values in these samples. After screening all samples whose ceRNAs were not statistically independently expressed, we performed Pearson correlation tests for lncRNA and mRNA expression in these samples. ceRNA relationships in these samples were retained only when the correlation coefficient was positive, and the <italic toggle="yes">P</italic>-value was less than 0.05. We collected 62 high-throughput expression profiles for 16 228 patients across 33 cancer types from the TCGA and GEO public datasets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S7</xref>). Detailed information of the data selection criteria and analysis pipeline is provided in the Supplementary Methods. We identified 93 307 patient-specific ceRNA regulations with a false discovery rate (FDR) &lt;0.05. Furthermore, we purified ceRNA pairs in a cancer-specific manner (Supplementary Methods). The specificity of the ceRNAs was characterized quantitatively by calculating the specificity score using a previously described method (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B34" ref-type="bibr">34</xref>). To explore the ceRNA regulatory mechanisms behind different individual phenotypes, we collected detailed clinical and pathological information such as tumor metastasis, recurrence, drug resistance and survival status for each patient. The incorporation of personalized ceRNA networks, clinical and pathological characteristics, and functional backgrounds will provide insights into individual pathology analysis.</p>
    </sec>
    <sec id="SEC2-5">
      <title>DATABASE CONSTRUCTION AND IMPROVED USER INTERFACE</title>
      <p>LncACTdb 3.0, performed data management using MySQL software (v 5.5). The web pages were developed using Java server pages and deployed on the Tomcat web server (v6). Several Java script plugins such as jQuery (v1.11.3), Datatable (1.10.10), and ECharts (V4.0) were used for data table creation and visualization. All statistical analyses were performed using R framework (v3.6.3). The LncACTdb 3.0 database is freely available at <ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/LncACTdb" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/LncACTdb</ext-link> or <ext-link xlink:href="http://www.bio-bigdata.net/LncACTdb" ext-link-type="uri">http://www.bio-bigdata.net/LncACTdb</ext-link>. The version 2.0 of LncACTdb, also remains available. To access LncACTdb 2.0, users can visit links from the LncACTdb 3.0, homepage (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S8</xref>), or directly at <ext-link xlink:href="http://www.bio-bigdata.net/LncACTdb2.0" ext-link-type="uri">http://www.bio-bigdata.net/LncACTdb2.0</ext-link>.</p>
      <p>LncACTdb 3.0 provides a user-friendly web interface that enables users to search, browse, analyze, and download data in a few easy steps (Figure <xref rid="F2" ref-type="fig">2</xref>). On the ‘HOME’ page, a fast search engine is available for users to directly investigate data or perform analyses (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S8 and S9</xref>). We used the well-known lncRNA MALAT1 as an example to explore (i) related experimentally supported ceRNAs, (ii) patient-specific ceRNAs, (iii) clinical information of samples and (iv) biomarkers for diagnosis and therapy (Figure <xref rid="F2" ref-type="fig">2A</xref>). All possible records are displayed on the search results page (Figure <xref rid="F2" ref-type="fig">2B</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S9A</xref>). To obtain interesting records, users can flexibly reorder the results table by clicking on the headers of different columns. The first and last columns will lead users to the detailed information page indicating the related disease, number of competing miRNAs, dataset information, experimental validation methods, and number/percentage of patients in which this ceRNA can be found (Figure <xref rid="F2" ref-type="fig">2C</xref>). LncACTdb 3.0 also provides a browse page to access the dataset based on different classifications (Figure <xref rid="F2" ref-type="fig">2D</xref>). Furthermore, a panel of online tools for studying the regulatory mechanisms of ceRNAs has been developed (Figure <xref rid="F2" ref-type="fig">2E</xref>–<xref rid="F2" ref-type="fig">K</xref>). Using the function tool, users can explore lncRNA functions based on GO terms and biological pathways (Figure <xref rid="F2" ref-type="fig">2E</xref>). For a ceRNA, the Location tool provides all possible sub-cellular and extracellular vesicle locations of lncRNAs, miRNAs and mRNAs (Figure <xref rid="F2" ref-type="fig">2F</xref>). Survival analysis was performed and Kaplan–Meier survival curves were generated for a ceRNA interaction or a single gene (lncRNA, mRNA, miRNA or pseudogene) across 62 cancer datasets (Figure <xref rid="F2" ref-type="fig">2G</xref>). The hallmark and state tools allow users to study the ceRNA effects on 10 classic cancer hallmark processes and 14 tumor cell states at the individual level (Figure <xref rid="F2" ref-type="fig">2H</xref>–<xref rid="F2" ref-type="fig">I</xref>). For a certain disease, the Tree tool provides a ceRNA distribution across different samples, which allows users to explore ceRNA effects on the clinical and pathological status of different groups (Figure <xref rid="F2" ref-type="fig">2J</xref>). The network tool provides a global view of (i) all possible related ceRNA interactions of input lncRNA, (ii) patient-specific, and (iii) customized ceRNA networks in which the diseases and nodes were selected by users (Figure <xref rid="F2" ref-type="fig">2K</xref>). Users can adjust the network with different layouts, such as force-direct or circular. Moreover, to provide a summary of the present research situations of ceRNAs, a hot-point page illustrating statistics of the most visited items was developed for LncACTdb 3.0 (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S9B</xref>).</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Case study and workflow for LncACTdb 3.0. (<bold>A</bold>) LncRNA MATLAT1 was used as an example in the search interface. (<bold>B</bold>) Search results of MALAT1, including both predicted and experimentally supported ceRNA interactions and biomarker annotations. (<bold>C</bold>) Detailed information of ceRNAs. (<bold>D</bold>) The browse interface of LncACTdb 3.0. (<bold>E</bold>) CeRNA functions based on GO terms and biological pathways. (<bold>F</bold>) Possible sub-cellular and extracellular vesicle locations of ceRNAs. (<bold>G</bold>) Survival tool performs survival analysis and provides Kaplan–Meier survival curves for a ceRNA interaction. (<bold>H–I</bold>) Exploring the effects of ceRNA on hallmark processes for cancer and on tumor cell states. (<bold>J</bold>) Exploring how ceRNA affects the clinical and pathological status of different groups of patients. (<bold>K</bold>) The lncRNA-related, patient-specific, and user-designed ceRNA networks of LncACTdb 3.0.</p>
        </caption>
        <graphic xlink:href="gkab1092fig2" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC3">
    <title>CONCLUSIONS AND FUTURE DEVELOPMENT</title>
    <p>In the previous version of the LncACTdb database (version 1.0 and 2.0), only a limited number of ceRNA interactions were documented. With the gradual improvement of high-throughput technology and experimental methods, an increasing number of ceRNAs have been recently found, particularly from 2019 to 2021 (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>). Rapid emergence of related studies necessitates the collection of corresponding datasets into a new version of the LncACTdb database. Together with the development of precision medicine, the identification of patient-specific ceRNAs and networks will deepen the understanding of disease pathology and contribute to individual diagnosis and therapy. Thus, we developed LncACTdb 3.0, with more data and new features focusing on personalized ceRNA networks. The current version of LncACTdb documents 5669 experimentally validated ceRNA interactions across 25 species and more than 537 diseases/phenotypes through manual curation of &gt;6000 published manuscripts. Newly identified personalized lncRNA-associated ceRNA interactions and networks for 16 228 patients from 62 datasets were integrated into LncACTdb 3.0. To provide a more comprehensive annotation, thousands of diagnostic and therapeutic biomarkers, biological terms, pathway gene sets, sub-cellular and extracellular vesicle locations, and clinical and pathological information of patients were collected. As an upgrade, a panel of flexible tools to retrieve and analyze the data was developed. In LncACTdb 3.0, the identification of patient-specific gene regulation networks aids in understanding disease pathology at the individual level and further contribute to precision medicine. A rapid and continued increase in the number of high-confidential ceRNA datasets identified from experiments is expected in the future, and we will continually maintain and update the LncACTdb database with more datasets and improved services, thereby improving our understanding of lncRNAs and contributing to personalized cancer diagnosis and treatment.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC4">
    <title>DATA AVAILABILITY</title>
    <p>All the data could be downloaded from <ext-link xlink:href="http://bio-bigdata.hrbmu.edu.cn/LncACTdb/" ext-link-type="uri">http://bio-bigdata.hrbmu.edu.cn/LncACTdb/</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkab1092_Supplemental_File</label>
      <media xlink:href="gkab1092_supplemental_file.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec id="SEC5">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkab1092#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC6">
    <title>FUNDING</title>
    <p>National Key R&amp;D Program of China [2018YFC2000100]; National Natural Science Foundation of China [32070673, 32070622, 32070672, 61873075, 62172131, 81902646]; Heilongjiang Touyan Innovation Team Program; Heilongjiang Provincial Natural Science Foundation [YQ2021C026]; Postdoctoral Science Foundation of China [2020M670922]; Postdoctoral Foundation of Heilongjiang Province [LBH-Z19077, LBH-Q20047]. Funding for open access charge: National Key R&amp;D Program of China [2018YFC2000100]; National Natural Science Foundation of China [32070673, 32070622, 32070672, 61873075, 62172131, 81902646]; Heilongjiang Touyan Innovation Team Program; Heilongjiang Provincial Natural Science Foundation [YQ2021C026]; Postdoctoral Science Foundation of China [2020M670922]; Postdoctoral Foundation of Heilongjiang Province [LBH-Z19077, LBH-Q20047].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ingolia</surname><given-names>N.T.</given-names></string-name>, <string-name><surname>Weissman</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Bartel</surname><given-names>D.P.</given-names></string-name></person-group><article-title>Mammalian microRNAs predominantly act to decrease target mRNA levels</article-title>. <source>Nature</source>. <year>2010</year>; <volume>466</volume>:<fpage>835</fpage>–<lpage>840</lpage>.<pub-id pub-id-type="pmid">20703300</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hendrickson</surname><given-names>D.G.</given-names></string-name>, <string-name><surname>Hogan</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>McCullough</surname><given-names>H.L.</given-names></string-name>, <string-name><surname>Myers</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Herschlag</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ferrell</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>P.O.</given-names></string-name></person-group><article-title>Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA</article-title>. <source>PLoS Biol.</source><year>2009</year>; <volume>7</volume>:<fpage>e1000238</fpage>.<pub-id pub-id-type="pmid">19901979</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kozomara</surname><given-names>A.</given-names></string-name>, <string-name><surname>Birgaoanu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Griffiths-Jones</surname><given-names>S.</given-names></string-name></person-group><article-title>miRBase: from microRNA sequences to function</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D155</fpage>–<lpage>D162</lpage>.<pub-id pub-id-type="pmid">30423142</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paraskevopoulou</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Georgakilas</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kostoulas</surname><given-names>N.</given-names></string-name>, <string-name><surname>Reczko</surname><given-names>M.</given-names></string-name>, <string-name><surname>Maragkakis</surname><given-names>M.</given-names></string-name>, <string-name><surname>Dalamagas</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Hatzigeorgiou</surname><given-names>A.G.</given-names></string-name></person-group><article-title>DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs</article-title>. <source>Nucleic Acids Res.</source><year>2013</year>; <volume>41</volume>:<fpage>D239</fpage>–<lpage>D245</lpage>.<pub-id pub-id-type="pmid">23193281</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salmena</surname><given-names>L.</given-names></string-name>, <string-name><surname>Poliseno</surname><given-names>L.</given-names></string-name>, <string-name><surname>Tay</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Kats</surname><given-names>L.</given-names></string-name>, <string-name><surname>Pandolfi</surname><given-names>P.P.</given-names></string-name></person-group><article-title>A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?</article-title>. <source>Cell</source>. <year>2011</year>; <volume>146</volume>:<fpage>353</fpage>–<lpage>358</lpage>.<pub-id pub-id-type="pmid">21802130</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seitz</surname><given-names>H.</given-names></string-name></person-group><article-title>Redefining microRNA targets</article-title>. <source>Curr. Biol.</source><year>2009</year>; <volume>19</volume>:<fpage>870</fpage>–<lpage>873</lpage>.<pub-id pub-id-type="pmid">19375315</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qi</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.H.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>N.</given-names></string-name>, <string-name><surname>Xiao</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>W.</given-names></string-name></person-group><article-title>ceRNA in cancer: possible functions and clinical implications</article-title>. <source>J. Med. Genet.</source><year>2015</year>; <volume>52</volume>:<fpage>710</fpage>–<lpage>718</lpage>.<pub-id pub-id-type="pmid">26358722</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Selbach</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schwanhäusser</surname><given-names>B.</given-names></string-name>, <string-name><surname>Thierfelder</surname><given-names>N.</given-names></string-name>, <string-name><surname>Fang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Khanin</surname><given-names>R.</given-names></string-name>, <string-name><surname>Rajewsky</surname><given-names>N.</given-names></string-name></person-group><article-title>Widespread changes in protein synthesis induced by microRNAs</article-title>. <source>Nature</source>. <year>2008</year>; <volume>455</volume>:<fpage>58</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">18668040</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>X.H.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nie</surname><given-names>F.Q.</given-names></string-name>, <string-name><surname>Ge</surname><given-names>Y.B.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>E.B.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>D.D.</given-names></string-name>, <string-name><surname>Kong</surname><given-names>R.</given-names></string-name>, <string-name><surname>Xia</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>K.H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer</article-title>. <source>Mol. Cancer</source>. <year>2014</year>; <volume>13</volume>:<fpage>92</fpage>.<pub-id pub-id-type="pmid">24775712</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>A.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Lei</surname><given-names>J.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Leng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Li</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>LncTarD: a manually-curated database of experimentally-supported functional lncRNA-target regulations in human diseases</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D118</fpage>–<lpage>D126</lpage>.<pub-id pub-id-type="pmid">31713618</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Das</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ghosal</surname><given-names>S.</given-names></string-name>, <string-name><surname>Sen</surname><given-names>R.</given-names></string-name>, <string-name><surname>Chakrabarti</surname><given-names>J.</given-names></string-name></person-group><article-title>lnCeDB: database of human long noncoding RNA acting as competing endogenous RNA</article-title>. <source>PLoS One</source>. <year>2014</year>; <volume>9</volume>:<fpage>e98965</fpage>.<pub-id pub-id-type="pmid">24926662</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H.</given-names></string-name>, <string-name><surname>Qu</surname><given-names>L.H.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>J.H.</given-names></string-name></person-group><article-title>starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>; <volume>42</volume>:<fpage>D92</fpage>–<lpage>D97</lpage>.<pub-id pub-id-type="pmid">24297251</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karagkouni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Paraskevopoulou</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Tastsoglou</surname><given-names>S.</given-names></string-name>, <string-name><surname>Skoufos</surname><given-names>G.</given-names></string-name>, <string-name><surname>Karavangeli</surname><given-names>A.</given-names></string-name>, <string-name><surname>Pierros</surname><given-names>V.</given-names></string-name>, <string-name><surname>Zacharopoulou</surname><given-names>E.</given-names></string-name>, <string-name><surname>Hatzigeorgiou</surname><given-names>A.G.</given-names></string-name></person-group><article-title>DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D101</fpage>–<lpage>D110</lpage>.<pub-id pub-id-type="pmid">31732741</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zhi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name></person-group><article-title>miRSponge: a manually curated database for experimentally supported miRNA sponges and ceRNAs</article-title>. <source>Database</source>. <year>2015</year>; <volume>2015</volume>:<fpage>bav098</fpage>.<pub-id pub-id-type="pmid">26424084</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yuan</surname><given-names>C.</given-names></string-name>, <string-name><surname>Meng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Illing</surname><given-names>N.</given-names></string-name>, <string-name><surname>Ingle</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>M.</given-names></string-name></person-group><article-title>PceRBase: a database of plant competing endogenous RNA</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D1009</fpage>–<lpage>D1014</lpage>.<pub-id pub-id-type="pmid">28053167</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>R.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>T.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name></person-group><article-title>Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>3478</fpage>–<lpage>3489</lpage>.<pub-id pub-id-type="pmid">25800746</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Fang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>D.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>LncACTdb 2.0: an updated database of experimentally supported ceRNA interactions curated from low- and high-throughput experiments</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D121</fpage>–<lpage>D127</lpage>.<pub-id pub-id-type="pmid">30476305</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barrett</surname><given-names>T.</given-names></string-name>, <string-name><surname>Troup</surname><given-names>D.B.</given-names></string-name>, <string-name><surname>Wilhite</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Ledoux</surname><given-names>P.</given-names></string-name>, <string-name><surname>Rudnev</surname><given-names>D.</given-names></string-name>, <string-name><surname>Evangelista</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>I.F.</given-names></string-name>, <string-name><surname>Soboleva</surname><given-names>A.</given-names></string-name>, <string-name><surname>Tomashevsky</surname><given-names>M.</given-names></string-name>, <string-name><surname>Edgar</surname><given-names>R.</given-names></string-name></person-group><article-title>NCBI GEO: mining tens of millions of expression profiles–database and tools update</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>; <volume>35</volume>:<fpage>D760</fpage>–<lpage>D765</lpage>.<pub-id pub-id-type="pmid">17099226</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>He</surname><given-names>X.</given-names></string-name><etal>et al</etal>.</person-group><article-title>exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>D106</fpage>–<lpage>D112</lpage>.<pub-id pub-id-type="pmid">30053265</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>T.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.</given-names></string-name>, <string-name><surname>Miao</surname><given-names>Y.R.</given-names></string-name>, <string-name><surname>Lei</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>A.Y.</given-names></string-name></person-group><article-title>EVmiRNA: a database of miRNA profiling in extracellular vesicles</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D89</fpage>–<lpage>D93</lpage>.<pub-id pub-id-type="pmid">30335161</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mas-Ponte</surname><given-names>D.</given-names></string-name>, <string-name><surname>Carlevaro-Fita</surname><given-names>J.</given-names></string-name>, <string-name><surname>Palumbo</surname><given-names>E.</given-names></string-name>, <string-name><surname>Hermoso Pulido</surname><given-names>T.</given-names></string-name>, <string-name><surname>Guigo</surname><given-names>R.</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>R.</given-names></string-name></person-group><article-title>LncATLAS database for subcellular localization of long noncoding RNAs</article-title>. <source>RNA</source>. <year>2017</year>; <volume>23</volume>:<fpage>1080</fpage>–<lpage>1087</lpage>.<pub-id pub-id-type="pmid">28386015</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quek</surname><given-names>X.C.</given-names></string-name>, <string-name><surname>Thomson</surname><given-names>D.W.</given-names></string-name>, <string-name><surname>Maag</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Bartonicek</surname><given-names>N.</given-names></string-name>, <string-name><surname>Signal</surname><given-names>B.</given-names></string-name>, <string-name><surname>Clark</surname><given-names>M.B.</given-names></string-name>, <string-name><surname>Gloss</surname><given-names>B.S.</given-names></string-name>, <string-name><surname>Dinger</surname><given-names>M.E.</given-names></string-name></person-group><article-title>lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>D168</fpage>–<lpage>D173</lpage>.<pub-id pub-id-type="pmid">25332394</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xia</surname><given-names>S.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>K.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>F.</given-names></string-name>, <string-name><surname>Jin</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xia</surname><given-names>L.</given-names></string-name>, <string-name><surname>Chang</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>CSCD: a database for cancer-specific circular RNAs</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>D925</fpage>–<lpage>D929</lpage>.<pub-id pub-id-type="pmid">29036403</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Shang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Zhi</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D1251</fpage>–<lpage>D1258</lpage>.<pub-id pub-id-type="pmid">33219685</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Shang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhi</surname><given-names>H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>LnCeVar: a comprehensive database of genomic variations that disturb ceRNA network regulation</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D111</fpage>–<lpage>D117</lpage>.<pub-id pub-id-type="pmid">31617563</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tay</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Rinn</surname><given-names>J.</given-names></string-name>, <string-name><surname>Pandolfi</surname><given-names>P.P.</given-names></string-name></person-group><article-title>The multilayered complexity of ceRNA crosstalk and competition</article-title>. <source>Nature</source>. <year>2014</year>; <volume>505</volume>:<fpage>344</fpage>–<lpage>352</lpage>.<pub-id pub-id-type="pmid">24429633</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>H.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Leng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Lei</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes</article-title>. <source>Mol. Ther. Nucleic Acids</source>. <year>2021</year>; <volume>23</volume>:<fpage>667</fpage>–<lpage>681</lpage>.<pub-id pub-id-type="pmid">33575113</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Harford</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Moghe</surname><given-names>M.</given-names></string-name>, <string-name><surname>Rait</surname><given-names>A.</given-names></string-name>, <string-name><surname>Pirollo</surname><given-names>K.F.</given-names></string-name>, <string-name><surname>Chang</surname><given-names>E.H.</given-names></string-name></person-group><article-title>Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>1424</fpage>–<lpage>1440</lpage>.<pub-id pub-id-type="pmid">29202181</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Hao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Shang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>LnCeCell: a comprehensive database of predicted lncRNA-associated ceRNA networks at single-cell resolution</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D125</fpage>–<lpage>D133</lpage>.<pub-id pub-id-type="pmid">33219686</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hanahan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Weinberg</surname><given-names>R.A.</given-names></string-name></person-group><article-title>Hallmarks of cancer: the next generation</article-title>. <source>Cell</source>. <year>2011</year>; <volume>144</volume>:<fpage>646</fpage>–<lpage>674</lpage>.<pub-id pub-id-type="pmid">21376230</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yuan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>W.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>C.</given-names></string-name>, <string-name><surname>Liao</surname><given-names>G.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Luo</surname><given-names>T.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>H.</given-names></string-name>, <string-name><surname>Long</surname><given-names>Z.</given-names></string-name><etal>et al</etal>.</person-group><article-title>CancerSEA: a cancer single-cell state atlas</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D900</fpage>–<lpage>D908</lpage>.<pub-id pub-id-type="pmid">30329142</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dai</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>T.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name></person-group><article-title>Cell-specific network constructed by single-cell RNA sequencing data</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>e62</fpage>.<pub-id pub-id-type="pmid">30864667</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yanai</surname><given-names>I.</given-names></string-name>, <string-name><surname>Benjamin</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shmoish</surname><given-names>M.</given-names></string-name>, <string-name><surname>Chalifa-Caspi</surname><given-names>V.</given-names></string-name>, <string-name><surname>Shklar</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ophir</surname><given-names>R.</given-names></string-name>, <string-name><surname>Bar-Even</surname><given-names>A.</given-names></string-name>, <string-name><surname>Horn-Saban</surname><given-names>S.</given-names></string-name>, <string-name><surname>Safran</surname><given-names>M.</given-names></string-name>, <string-name><surname>Domany</surname><given-names>E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification</article-title>. <source>Bioinformatics</source>. <year>2005</year>; <volume>21</volume>:<fpage>650</fpage>–<lpage>659</lpage>.<pub-id pub-id-type="pmid">15388519</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Hao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>P.</given-names></string-name></person-group><article-title>Dynamic TF-lncRNA regulatory networks revealed prognostic signatures in the development of ovarian cancer</article-title>. <source>Front. Bioeng. Biotechnol.</source><year>2020</year>; <volume>8</volume>:<fpage>460</fpage>.<pub-id pub-id-type="pmid">32478062</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
